New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
07:41 EDTFLDMFluidigm price target lowered to $52 from $65 at Maxim
Maxim lowered its price target for Fluidigm shares to $52 saying the company's Proteomics business pipeline is expected to take longer to convert than previously anticipated. The firm reiterates a Buy rating on the stock, however, saying the company's Q1 results were strong.
News For FLDM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 8, 2015
08:45 EDTFLDMLife Sciences group well positioned heading into Q1 earnings, says Cowen
Cowen said the Life Sciences sector looks well positioned heading into Q1 earnings despite the group outperforming the broader market recently. The firm believes headwinds have intensified and multiples have stretched, but they see the downside risk as limited with upside risk dependent on improving end-market commentary, new products and milestones, and new details on capital deployment. Stocks in the space include Affymetrix (AFFX), Fluidigm (FLDM), GenMark (GNMK), Myriad Genetics (MYGN) and Quidel (QDEL).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use